Antiemetic Drugs Market Analysis: By Type of Drug (5-HT3 receptor antagonists, Dopamine antagonists, Steroid-Corticosteroids, Benzodiazepines, NK1 receptor antagonist, Antihistamines, Cannabinoids); By Applications With Forecast (2016-2021)

  • ID: 3919995
  • Report
  • 133 pages
  • IndustryARC
1 of 3
Antiemetic drugs are those that have the ability to treat conditions such as nausea and vomitting. They can be used to treat the aforementioned conditions caused by a range of illnesses. Chemotherapy for cancer patients, food poisoning, gastroenteritis, motion sickness and so on can be treated by antiemetic drugs. In case of pregnant women, these drugs bring significant relief to women who have to endure bouts of morning sickness, either during the early phase of the pregnancy. For some women, the morning sickness lasts for much longer and antiemetic drugs are extremely useful in such situations.

Increasing number of people being affected with different types of cancer is another factor driving the growth of the antiemetic drug market. Chemotherapy is one of the standard treatments used to deal with cancer and is also accompanied by side effects of nausea and vomitting. In fact, chemotherapy actually accounts for the largest share of all the applications of the global antiemetic drugs market.

The time to market and the limited resources for clinical trials and animal testing a factors that are inhibiting the growth of this market. There is a lot of funding devoted to research and development efforts and this can negate some of the growth inhibitors of the antiemetic drug market.

Antiemetic Drugs Market

The Antiemetic Drugs market can be segmented on the basis of type of drug as

5-HT3 receptor antagonists
Dopamine antagonists
NK1 receptor antagonist

In terms of applications, the Antiemetic Drugs market has been segmented across the following

Motion Sickness
Food Poisoning
General Anesthetics
Opiod Analgesics
Emotional Stress

North America followed by Europe currently dominate the global antiemetic drugs market and this trend is anticipated to hold good till the end of the forecast period considered in this report. In Asia Pacific, the rapidly increasing population has the potential to further the growth of this market. There is also a general increase in several lifestyle related diseases across the world and this can also potentially drive the growth of this market.

The market has been segmented based on the following geographies:

North America
South America
Middle East

The antiemetics drug market is highly competitive. Following are just a few of the companies that are operating in the Antiemetic Drugs market:

Baxter International
Novartis AG
Johnson and Johnson
GlaxoSmithKline Plc
Cipla Ltd.
Please Note: The report is to be delivered in 1-2 working days after an order is placed.
Note: Product cover images may vary from those shown
2 of 3
1. Antiemetic Drugs Market Overview
2. Executive Summary
3. Antiemetic Drugs Market Landscape
3.1. Market Share Analysis
3.2. Comparative Analysis
3.2.1. Product Benchmarking
3.2.2. End User Profiling
3.2.3. Top 5 Financials Analysis
4. Antiemetic Drugs Market Forces
4.1. Market Drivers
4.2. Market Constraints
4.3. Market Challenges
4.4. Attractiveness of the Antiemetic Drugs Market
4.4.1. Power of Suppliers
4.4.2. Power of Customers
4.4.3. Threat of New Entrants
4.4.4. Threat of Substitution
4.4.5. Degree of Competition
5. Antiemetic Drugs Market - Strategic Analysis
5.1. Value Chain Analysis
5.2. Pricing Analysis
5.3. Opportunities Analysis
5.4. Product/Market Life Cycle Analysis
5.5. Suppliers and Distributors
6. Antiemetic Drugs Market By Type of Drug
6.1. 5-HT3 receptor antagonists
6.2. Dopamine antagonists
6.3. Steroid-Corticosteroids
6.4. Benzodiazepines
6.5. NK1 receptor antagonist
6.6. Antihistamines
6.7. Cannabinoids
6.8. Anticholinergic
6.9. Others
7. Antiemetic Drugs Market By Application
7.1. Chemotherapy
7.2. Pregnancy
7.3. Motion Sickness
7.4. Food Poisoning
7.5. Gastroenteritis
7.6. Diziness
7.7. General Anesthetics
7.8. Opiod Analgesics
7.9. Emotional Stress
7.10. Others
8. Antiemetic Drugs Market By Geography
8.1. Introduction
8.2. Global Study
8.3. Americas
8.3.1. North America
8.3.2. Brazil
8.3.3. Argentina
8.3.4. Others
8.4. Europe
8.4.1. U.K.
8.4.2. France
8.4.3. Germany
8.4.4. Others
8.5. APAC
8.5.1. China
8.5.2. Japan
8.5.3. India
8.5.4. Others
8.6. ROW
9. Antiemetic Drugs Market Entropy
9.1. New Product Launches
9.2. M&As, Collaborations, JVs and Partnerships
10. Company Profiles
10.1. GlaxoSmithKline
10.2. Pfizer Inc.
10.3. Johnson and Johnson
10.4. Astellas Pharma
10.5. Merck
10.6. Sanofi-Aventis
10.7. Baxter International
10.8. Abbott Labs
10.9. Cipla Ltd.
10.10. Novartis AG

"*Financials would be provided on a best efforts basis for private companies"
11. Appendix
11.1. Abbreviations
11.2. Sources
11.3. Research Methodology
11.4. Bibliography
11.5. Compilation of Expert Insights
11.6. Disclaimer
Note: Product cover images may vary from those shown
3 of 3


4 of 3
Note: Product cover images may vary from those shown